[1]William B, Julia W. Acute liver failure\[J\]. N Engl J Med, 2013,369(26): 2525-2534.
[2]Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection\[J\]. J Gastroenterol Hepatol, 2003,18(8): 891-902.
[3]Borrelli DA, Yankson K, Shukla N, et al. Extracellular vesicle therapeutics for liver disease\[J\]. J Control Release, 2018,273: 86-98.
[4]Liu X, Wang T, Liu X, et al. Biochanin A protects lipopolysaccharide/Dgalactosamineinduced acute liver injury in mice by activating the Nrf 2 pathway and inhibiting NLRP3 inflammasome activation\[J\]. Int Immunopharmacol, 2016,38: 324-331.
[5]Haga H, Yan IK, Takahashi K, et al. Extracellular vesicles from bone marrowderived mesenchymal stem cells improve survival from lethal hepatic failure in mice\[J\]. Stem Cells Transl Med, 2017,6(4): 1262-1272.
[6]Yang D, Yuan Q, Balakrishnan A, et al. MicroRNA125b5p mimic inhibits acute liver failure\[J\]. Nat Commun, 2016,7: 11916.
[7]Woolbright BL, Jaeschke H. Role of the inflammasome in acetaminopheninduced liver injury and acute liver failure\[J\]. J Hepatol, 2017,66(4): 836-848.
[8]Jin G, Qiu G, Wu D, et al. Allogeneic bone marrowderived mesenchymal stem cells attenuate hepatic ischemiareperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats\[J\]. Int J Mol Med, 2013,31(6): 1395-1401.
[9]Cheng K, Rai P, Plagov A, et al. Transplantation of bone marrowderived MSCs improves cisplatinuminduced renal injury through paracrine mechanisms\[J\]. Exp Mol Pathol, 2013,94(3): 466-473.
[10]Schrepfer S, Deuse T, Reichenspurner H, et al. Stem cell transplantation: the lung barrier\[J\]. Transplant Proc, 2007,39(2): 573-576.
[11]Eggenhofer E, Benseler V, Kroemer A, et al. Mesenchymal stem cells are shortlived and do not migrate beyond the lungs after intravenous infusion\[J\]. Front Immunol, 2012,3: 297.
[12]Veerman RE, Gülüler Akpinar G, Eldh M, et al. Immune cellderived extracellular vesiclesfunctions and therapeutic applications\[J\].Trends Mol Med, 2019, 25(5): 382-394.
[13]Gudbergsson JM, Jnsson K, Simonsen JB, et al. Systematic review of targeted extracellular vesicles for drug deliveryconsiderations on methodological and biological heterogeneity\[J\]. J Control Release, 2019,306: 108-120.
[14]Mathieu M, MartinJaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for celltocell communication\[J\]. Nat Cell Biol, 2019,21(1): 9-17.
[15]Gangadaran P, Rajendran RL, Lee HW, et al. Extracellular vesicles from mesenchymal stem cells activates VEGF receptors and accelerates recovery of hindlimb ischemia\[J\]. J Control Release, 2017,264: 112-126.
[16]翟骁, 王一然, 朱明向,等.间充质干细胞来源外泌体在氧化应激损伤中的研究进展\[J\].第二军医大学学报,2018,39(7): 716-721.
[17]Jiang W, Tan Y, Cai M, et al. Human umbilical cord MSCderived exosomes suppress the development of CCl4induced liver injury through antioxidant effect\[J\]. Stem Cells Int, 2018,2018: 1-11.
[18]Yan Y, Jiang W, Tan Y, et al. hucMSC exosomederived GPX1 is required for the recovery of hepatic oxidant injury\[J\]. Mol Ther, 2017,25(2): 465-479.
[19]Wang K, Jiang Z, Webster KA, et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA21\[J\]. Stem Cells Transl Med, 2017,6(1): 209-222.
[20]Lin KC, Yip HK, Shao PL, et al. Combination of adiposederived mesenchymal stem cells(ADMSC) and ADMSCderived exosomes for protecting kidney from acute ischemiareperfusion injury\[J\]. Int J Cardiol, 2016,216: 173-185.
|